With a market cap of $11.3 billion, Bio-Techne Corporation (TECH) is a global life sciences company that develops, ...

June 25 (Reuters) - Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $11.3 billion, the German science and healthcare firm said in a statement on Thursday. Shares of Bio-Techne rose ...

German drugmaker Merck ​KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade.

The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

Develops and manufactures life science reagents, analytical instruments, and diagnostic products, including proteins, antibodies, assays, and molecular diagnostic kits Generates revenue through the ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.

MINNEAPOLIS, June 11, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of ...

MINNEAPOLIS, June 9, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) is at the forefront of coronavirus disease 2019 (COVID-19) and SARS-CoV-2 research. This is evidenced by the large number ...